Endostar Combined With NVB and DDP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

NCT02665702 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: NVB
DRUG: DDP
DRUG: Endostar

Sponsor

Fudan University